◄ back to all posts

GSK: GlaxoSmithKline plc Stock

Written by | Jul 6, 2018

SIC 2834 – Pharmaceutical Preparations

Market Cap ($M) 87,831.16
Enterprise Value ($M) n/a
Book Value ($M) n/a
Book Value / Share n/a
Price / Book n/a
NCAV ($M) n/a
NCAV / Share n/a
Price / NCAV n/a

Profitability (mra)
Return on Invested Capital (ROIC) n/a
Return on Assets (ROA) n/a
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio n/a
Current Ratio n/a

Balance Sheet (mrq) ($M)
Current Assets n/a
Assets n/a
Liabilities n/a
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue n/a
Operating Income n/a
Net Income n/a

Cash Flow Statement (mra) ($M)
Cash From Operations n/a
Cash from Investing n/a
Cash from Financing n/a

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
2020-02-05 13G/A BlackRock Inc. 7.50 9.28

Top 13F Investors Shares

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2020-10-23 457,150 5,153,700 8.87
2020-10-22 908,351 6,903,700 13.16
2020-10-21 1,059,875 7,760,100 13.66
2020-10-20 950,059 5,306,300 17.90
2020-10-19 558,878 3,487,100 16.03

(click for more detail)

(click for list of largest short owners)

Similar Companies
EBS – Emergent Biosolutions, Inc. ELAN – Elanco Animal Health Inc
FRX – Forest Laboratories Inc HEXO – HEXO Corp.
HSP – Hospira

Financial data and stock pages provided by

Finpedia: GlaxoSmithKline Pharmaceuticals Ltd

◄ back to all posts